Skip to main content
Fig. 2 | Chinese Medicine

Fig. 2

From: Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s disease

Fig. 2

A the swimming track of rats; B the latency speed of rats; C the latency distance of rats; D the number of rats crossing the platform; E the number of rats crossing the platform during training. F–I Aβ immunohistochemistry in different groups. *represents a comparison with the Model group (*p < 0.05, **p < 0.01)

Back to article page